TY - JOUR
T1 - CHARGE syndrome modeling using patient-iPSCs reveals defective migration of neural crest cells harboring CHD7 mutations
AU - Okuno, Hironobu
AU - Mihara, Francois Renault
AU - Ohta, Shigeki
AU - Fukuda, Kimiko
AU - Kurosawa, Kenji
AU - Akamatsu, Wado
AU - Sanosaka, Tsukasa
AU - Kohyama, Jun
AU - Hayashi, Kanehiro
AU - Nakajima, Kazunori
AU - Takahashi, Takao
AU - Wysocka, Joanna
AU - Kosaki, Kenjiro
AU - Okano, Hideyuki
N1 - Publisher Copyright:
© Okuno et al.
PY - 2017/11/28
Y1 - 2017/11/28
N2 - CHARGE syndrome is caused by heterozygous mutations in the chromatin remodeler, CHD7, and is characterized by a set of malformations that, on clinical grounds, were historically postulated to arise from defects in neural crest formation during embryogenesis. To better delineate neural crest defects in CHARGE syndrome, we generated induced pluripotent stem cells (iPSCs) from two patients with typical syndrome manifestations, and characterized neural crest cells differentiated in vitro from these iPSCs (iPSC-NCCs). We found that expression of genes associated with cell migration was altered in CHARGE iPSC-NCCs compared to control iPSC-NCCs. Consistently, CHARGE iPSC-NCCs showed defective delamination, migration and motility in vitro, and their transplantation in ovo revealed overall defective migratory activity in the chick embryo. These results support the historical inference that CHARGE syndrome patients exhibit defects in neural crest migration, and provide the first successful application of patient-derived iPSCs in modeling craniofacial disorders.
AB - CHARGE syndrome is caused by heterozygous mutations in the chromatin remodeler, CHD7, and is characterized by a set of malformations that, on clinical grounds, were historically postulated to arise from defects in neural crest formation during embryogenesis. To better delineate neural crest defects in CHARGE syndrome, we generated induced pluripotent stem cells (iPSCs) from two patients with typical syndrome manifestations, and characterized neural crest cells differentiated in vitro from these iPSCs (iPSC-NCCs). We found that expression of genes associated with cell migration was altered in CHARGE iPSC-NCCs compared to control iPSC-NCCs. Consistently, CHARGE iPSC-NCCs showed defective delamination, migration and motility in vitro, and their transplantation in ovo revealed overall defective migratory activity in the chick embryo. These results support the historical inference that CHARGE syndrome patients exhibit defects in neural crest migration, and provide the first successful application of patient-derived iPSCs in modeling craniofacial disorders.
UR - https://www.scopus.com/pages/publications/85036494994
UR - https://www.scopus.com/pages/publications/85036494994#tab=citedBy
U2 - 10.7554/eLife.21114
DO - 10.7554/eLife.21114
M3 - Article
C2 - 29179815
AN - SCOPUS:85036494994
SN - 2050-084X
VL - 6
JO - eLife
JF - eLife
M1 - e21114
ER -